Can ZETA SURGICAL turn brain biopsy and hydrocephalus procedures into point-of-care care?
Neurosurgery needs precision beyond elite hospitals. ZETA SURGICAL’s FDA clearance puts AI-guided access to the real-world test.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
FDA clears Olympus POWERSEAL Open Extended Jaw as surgical energy competition grows
Olympus cleared a new POWERSEAL device, but adoption now depends on surgeon trust, hospital value reviews, and open surgery workflow gains.
Medical Devices & Diagnostics
Can Chest Wall Innovations turn FDA clearance into adoption in rib fixation?
Rib fixation is gaining clinical ground. Chest Wall Innovations now faces the harder test: converting FDA clearance into surgeon adoption.
Medical Devices & Diagnostics
Why Abbott’s Ultreon 3.0 could reshape stent planning in complex coronary disease
AI can now guide coronary imaging in real time. Abbott’s Ultreon 3.0 puts precision PCI closer to routine clinical workflow.
Medical Devices & Diagnostics
Why Pulse Biosciences’ 12-month nsPFA data matters in a PFA market dominated by Farapulse and Affera
Boston Scientific owns the PFA market. Pulse Biosciences just posted 90% one-year AF freedom. Is nanosecond PFA a real disruption or an acquisition target?
Medical Devices & Diagnostics
Can Utepreva’s new device solve the biggest problem in endometrial cancer diagnosis?
Utepreva’s FDA-cleared endometrial sampler promises earlier cancer detection. Find out how this device could reshape diagnostics today.
Medical Devices & Diagnostics
Medtronic backs Pulnovo Medical in $100m round to expand PADN in pulmonary hypertension
Pulnovo Medical raised $100 million with Medtronic backing. Read what it means for PADN, pulmonary hypertension, heart failure, and device markets.
Medical Devices & Diagnostics
Why Miracell’s SMART M-CELL FDA clearance could reshape the PRP and BMAC device market
Miracell has won FDA 510(k) clearance for SMART M-CELL. Read what it changes for PRP, BMAC, adoption, and regenerative medicine competition.
Medical Devices & Diagnostics
Why InterVene’s first 30 Recana cases could reshape treatment for venous in-stent restenosis
InterVene has completed 30 Recana cases, raising new questions about venous ISR treatment, adoption, and launch strategy. Read the full analysis.
Medical Devices & Diagnostics
Can VR LIFE and H2 Global Group turn European MedTech validation into real global scale?
Can VR LIFE and H2 Global Group scale from European validation to global MedTech relevance? Read the deeper analysis now.